Krystal Biotech, Inc. (KRYS) operating KPIs
KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/30111% above fair value
$332.29+7.74 (+2.38%)
Close on Oct 30, 2026Market cap $9.84BP/E 41.6Yield –
KPIs
Operating metrics that drive Krystal Biotech's business
Coming soon
This tab will track the numbers specific to Krystal Biotech's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.